Latest news
Goldman Sachs Keeps Their Hold Rating on Crispr Therapeutics AG (CRSP) - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 12:02:00 GMTRBC Capital Keeps Their Hold Rating on Crispr Therapeutics AG (CRSP) - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 01:54:00 GMTOppenheimer Keeps Their Hold Rating on Eaton (ETN) - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 04:18:00 GMTOppenheimer Keeps Their Hold Rating on Ameresco (AMRC) - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 03:30:00 GMTBernstein Keeps Their Hold Rating on Chevron (CVX) - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 13:38:00 GMTJefferies Keeps Their Hold Rating on National Grid (NG) - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 09:06:00 GMTBerenberg Bank Keeps Their Hold Rating on SFS Group AG (SFSN) - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 06:42:00 GMTBank of America Securities Keeps Their Hold Rating on Option Care Health (OPCH) - The Globe and MailThe Globe and Mail · Fri, 31 Jul 2026 10:58:00 GMT